文献速递中毒与环境急症重症综合管理与镇静镇痛

毒性浓度美他沙酮对单胺氧化酶A的抑制作用

Monoamine oxidase A inhibition by toxic concentrations of metaxalone.
PubMed 文献 · Clin Toxicol (Phila) · 2019-08-02
一句话结论体外模型显示,与病例报告中毒性浓度相近的美他沙酮可显著抑制单胺氧化酶A,临床医生应警惕其与5-羟色胺能药物联用时的致死性相互作用。

美他沙酮在治疗剂量或过量时与5-羟色胺再摄取抑制剂等5-羟色胺能药物联用可发生5-羟色胺毒性,其机制被推测为抑制单胺氧化酶A。本研究用体外模型将美他沙酮(1.56–400 µM)与专有MAO底物及重组人MAO-A孵育1小时,加入酯酶和荧光素酶后测定发光强度,并以已知MAO-A抑制剂氯吉兰作为阳性对照。结果显示美他沙酮对MAO-A活性呈显著剂量相关抑制,四参数逻辑回归分析显示随浓度增加存在强剂量-反应关系。作者认为,在病例报告中报道的毒性浓度下美他沙酮可显著抑制MAO-A,临床医生应认识这一机制,并将其作为5-羟色胺毒性的潜在原因,尤其在过量场景下。

要点

  • 体外模型中,美他沙酮浓度1.56–400 µM与重组人MAO-A孵育1小时后呈显著剂量相关MAO-A抑制。
  • 四参数逻辑回归分析显示,随美他沙酮浓度增加存在强剂量-反应关系。
  • 病例报告中美他沙酮相关5-羟色胺毒性的血药浓度为31–61 mcg/ml(140–276 µM)。
  • 作者认为,临床医生应认识美他沙酮抑制MAO-A的机制,尤其在与其它5-羟色胺能药物联用及过量场景下。

适用人群与场景

  • 使用治疗剂量5-羟色胺再摄取抑制剂等5-羟色胺能药物、同时使用美他沙酮(治疗剂量或过量)的患者。

红旗征与不能漏的情况

  • 作者认为,美他沙酮与其它5-羟色胺能药物联用时可发生潜在致死性相互作用,应将其视为5-羟色胺毒性的潜在原因,尤其在过量场景下。

研究设计与关键结果

  • 研究类型:体外模型研究。
  • 方法:美他沙酮浓度1.56–400 µM与专有MAO底物及重组人MAO-A孵育1小时,加入酯酶和荧光素酶后测定发光强度;以氯吉兰(已知MAO-A抑制剂)作为阳性对照;发光强度用Biotek Synergy HT微孔板读数仪测定。
  • 主要结果:美他沙酮对MAO-A活性呈显著剂量相关抑制;四参数逻辑回归分析显示随浓度增加存在强剂量-反应关系。
  • 病例报告中与5-羟色胺毒性相关的美他沙酮浓度为31–61 mcg/ml(140–276 µM)。

证据类型、等级与局限

  • 证据类型:体外研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,临床医生应认识美他沙酮抑制MAO-A的机制,理解其与其它5-羟色胺能药物联用时的潜在致死性相互作用,并将其作为5-羟色胺毒性的潜在原因,尤其在过量场景下。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Context: Serotonin toxicity is a reported complication associated with both therapeutic use and overdose of metaxalone while on therapeutic doses of serotonergic drugs such as serotonin reuptake inhibitors. Monoamine oxidase A (MAO-A) inhibition by metaxalone has been proposed as the etiology of this toxicity. Metaxalone concentrations reported with cases of serotonin toxicity range from 31 to 61 mcg/ml (140-276 µM). We investigated the effect of metaxalone on MAO-A activity using an in vitro model.Methods: Metaxalone at concentrations ranging from 1.56 to 400 µM were incubated with a proprietary MAO substrate and recombinant human MAO-A for 1 h. After that, an esterase and luciferase were added and luminescence measured. Clorgyline, a known MAO-A inhibitor, was used as a positive control. Luminescence was measured using a Biotek Synergy HT microplate reader.Results: Metaxalone demonstrated significant dose-related inhibition of MAO-A activity. Four-parameter logistic regression analysis demonstrated a strong dose-response relationship at increasing concentrations.Conclusions: Our in vitro model shows that at toxic concentrations similar to those reported in case reports metaxalone shows significant MAO-A inhibition. Clinicians should be aware of this mechanism and understand the potentially lethal interactions metaxalone can have when prescribed with other serotonergic drugs and consider this as a potential cause of serotonin toxicity, especially in overdose scenarios.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Cherrington B, Englich U, Niruntari S, et al. Monoamine oxidase A inhibition by toxic concentrations of metaxalone. Clin Toxicol (Phila). 2019. PMID: 31373522. doi:10.1080/15563650.2019.1648815

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。